Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
251.00    5.50 (2.24%)
Bid:
247.00
Ask:
248.00
Spread: 1.00 (0.405%)
Market Cap: £146.42m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Performance Share Plan award to Directors/PDMRs

12 Nov 2019 15:40

RNS Number : 1678T
MJ Gleeson PLC
12 November 2019
 

12 November 2019

 

MJ Gleeson plc ("Gleeson" or the "Company")

 

Performance Share Plan award to Directors/PDMRs

 

The Company announces that on 11 November 2019 Stefan Allanson, Chief Financial Officer, exercised share options ("Share Options") over 73,531 ordinary shares of 2 pence each in the capital of the Company ("Ordinary Shares") in connection with the Company's Long Term Incentive Plan ("LTIP").

 

Application has been made for the admission to trading of the new Ordinary Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, on the Main Market of the London Stock Exchange and to listing on the Official List of the UKLA, with dealings expected to commence on or around 15 November 2019.

 

Subsequent to the exercise and issue of the new Ordinary Shares, the Company has been notified that Stefan Allanson sold 34,663 Ordinary Shares at a price of £8.00 per Ordinary Share in order to satisfy tax liabilities resulting from the exercise of the above-mentioned options. Following the exercise and the sale, Stefan Allanson's shareholding has increased to 55,765 Ordinary Shares in the Company, representing 0.1 per cent. of the total voting rights in the Company.

 

Total Voting Rights

Following the issue of the new Ordinary Shares the total number of issued Ordinary Shares is 54,675,284. The Company does not hold any Ordinary Shares in Treasury.

 

Therefore, the total number of Ordinary Shares with voting rights is 54,675,284 which may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's DTR.

 

Enquiries:

MJ Gleeson plc Tel: 44 1142 612 900

James Thomson Interim Chief Executive Officer

Stefan Allanson Chief Financial Officer

 

Instinctif Partners Tel: 44 20 7457 2020

Mark Garraway

James Gray

 

N+1 Singer Tel: 44 20 7496 3000

Shaun Dobson

Rachel Hayes

 

Liberum Tel: 44 20 3100 2222

Neil Patel

Richard Bootle

 

The following notifications are intended to satisfy the Company's obligations under Article 19(3) of EU Regulation No 596/2014 (the Market Abuse Regulation).

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stefan Allanson

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

MJ Gleeson plc

b)

 

LEI

 

21380064K7N2W7FD6434

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 2 pence each

 

 

GB00BRKD9Z53

b)

 

Nature of the transaction

 

 

Exercise of Share Options

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil (exercise of options)

73,531

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

n/a

e)

 

Date of the transaction

 

 

11 November 2019

f)

 

Place of the transaction

 

 

Off market

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 2 pence each

 

 

GB00BRKD9Z53

b)

 

Nature of the transaction

 

 

Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

800p

34,663

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

n/a

e)

 

Date of the transaction

 

 

11 November 2019

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKBDNPBDDODD
Date   Source Headline
30th Dec 20227:00 amRNSTotal Voting Rights
15th Dec 202211:06 amRNSDirectorate External Appointments
12th Dec 20227:00 amRNSAppointment of Managing Director of Gleeson Land
8th Dec 20221:26 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSTotal Voting Rights
28th Nov 20223:46 pmRNSDirector/PDMR Shareholding
18th Nov 20221:05 pmRNSResult of AGM
18th Nov 20227:00 amRNSAGM Trading Update
8th Nov 202212:34 pmRNSDirector/PDMR Shareholding
4th Nov 20221:31 pmRNSDirector/PDMR Shareholding
1st Nov 20227:00 amRNSRe: Financial Calendar
31st Oct 20227:00 amRNSTotal Voting Rights
21st Oct 20224:21 pmRNSPerformance Share Plan award to Directors & PDMRs
20th Oct 20227:00 amRNSNotice of AGM
12th Oct 20227:00 amRNSRe Directorate
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Oct 20221:25 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSRe Directorate External Appointments
5th Oct 20224:15 pmRNSExercise of Options & PDMR Dealing
3rd Oct 202211:55 amRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSTotal Voting Rights
15th Sep 20227:00 amRNSFinal Results
7th Sep 20229:50 amRNSDirector/PDMR Shareholding
31st Aug 20227:00 amRNSTotal Voting Rights
9th Aug 20229:41 amRNSDirector/PDMR Shareholding
1st Aug 202211:28 amRNSNotification of Transaction by Directors/PCA
29th Jul 20227:00 amRNSTotal Voting Rights
14th Jul 20222:26 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSTrading Update & Notice of Results
7th Jul 20229:35 amRNSDirector/PDMR Shareholding
1st Jul 20227:05 amRNSMJ Gleeson achieves medium-term strategic target
30th Jun 20227:00 amRNSTotal Voting Rights
8th Jun 20222:53 pmRNSDirector/PDMR Shareholding
31st May 20227:00 amRNSTotal Voting Rights
12th May 20227:00 amRNSNotice of Trading Update & Results
10th May 20229:54 amRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSAppointment of Group Sustainability Manager
4th May 20221:09 pmRNSDirector/PDMR Shareholding
29th Apr 20223:30 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNSDirector/PDMR Shareholding
27th Apr 20227:00 amRNSRe Directorate Change
12th Apr 20224:51 pmRNSDirector/PDMR Shareholding
6th Apr 20227:00 amRNSRe DLUHC pledge
31st Mar 20227:00 amRNSTotal Voting Rights
25th Mar 20227:00 amRNSDirectorate changes and committee appointments
17th Mar 20227:00 amRNSDirectorate Change
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
10th Mar 20229:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.